mTHPC-loaded extracellular vesicles outperform liposomal and free mTHPC formulations by an increased stability, drug delivery efficiency and cytotoxic effect in tridimensional model of tumors

Abstract Efficient photodynamic therapy with meta-tetra(hydroxyphenyl)chlorine requires the application of specific nanoformulations. mTHPC liposomal formulation (Foslip®) demonstrated favorable pharmacokinetics properties. However, rapid liposomes destruction in circulation and rapid mTHPC release impedes Foslip® applications. Alternatively, mTHPC nanovectorization using extracellular vesicles (EVs) could be an attractive option. EVs are naturally secreted by the organism to play a role in intercellular communication due to the capacity to transport proteins and nucleic acids. EVs also possess a natural ability to deliver therapeutic molecules into cancer cells. The aim of the present study was to evaluate photophysical and photobiological properties of mTHPC loaded in endothelial EVs as nanocarriers. We also studied efficiency of nanovectorisation on mTHPC distribution and PDT activity in multicellular tumor spheroids (MCTSs). MCTS is a nonvascularized in vitro 3D model of cells that mimics a similar microenvironment to in vivo situation. mTHPC-EVs were characterized by means of spectroscopic techniques, flow cytometry and nanoparticle tracking analysis. Compared with Foslip®, mTHPC-EVs are stable in murine plasma. Better mTHPC accumulation and penetration (up to 100 µm) in MCTS was observed for mTHPC-EVs compared with liposomal mTHPC. These factors could explain enhanced photodynamic activity of mTHPC-EVs compared with free and liposomal mTHPC. The light dose inducing 50% of cell death with mTHPC-EVs was 4 and 2.5-times lower than that of free and liposomal mTHPC. The obtained results demonstrate that EVs should be considered as perspective nanocarriers for mTHPC-mediated PDT.

[1]  A. Fahr,et al.  Liposomes in topical photodynamic therapy , 2012, Expert opinion on drug delivery.

[2]  H. S. de Bruijn,et al.  Fluorescence localization and kinetics of mTHPC and liposomal formulations of mTHPC in the window‐chamber tumor model , 2011, Lasers in surgery and medicine.

[3]  R. Schiffelers,et al.  Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[4]  E. Korn,et al.  Interaction of phospholipid vesicles with cells. Endocytosis and fusion as alternate mechanisms for the uptake of lipid-soluble and water-soluble molecules , 1975, The Journal of cell biology.

[5]  Melani A Solomon,et al.  Development of an in vitro tumor spheroid culture model amenable to high-throughput testing of potential anticancer nanotherapeutics , 2016, Journal of liposome research.

[6]  Arjen Amelink,et al.  Ex vivo quantification of mTHPC concentration in tissue: influence of chemical extraction on the optical properties. , 2008, Journal of photochemistry and photobiology. B, Biology.

[7]  H. Maeda,et al.  A Retrospective 30 Years After Discovery of the Enhanced Permeability and Retention Effect of Solid Tumors: Next‐Generation Chemotherapeutics and Photodynamic Therapy—Problems, Solutions, and Prospects , 2016, Microcirculation.

[8]  T. Knobloch,et al.  Comparison of intracellular accumulation and cytotoxicity of free mTHPC and mTHPC-loaded PLGA nanoparticles in human colon carcinoma cells , 2011, Nanotechnology.

[9]  F. Berr,et al.  Comparative characterization of the efficiency and cellular pharmacokinetics of Foscan®- and Foslip®-based photodynamic treatment in human biliary tract cancer cell lines , 2007, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[10]  D. Vernon,et al.  Identification and Partial Characterization of an Unusual Distribution of the Photosensitizer meta‐Tetrahydroxyphenyl Chlorin (Temoporfin) in Human Plasma , 1999, Photochemistry and photobiology.

[11]  Ji-Ho Park,et al.  Liposome-based engineering of cells to package hydrophobic compounds in membrane vesicles for tumor penetration. , 2015, Nano letters.

[12]  F. Guillemin,et al.  Correlation between in vivo pharmacokinetics, intratumoral distribution and photodynamic efficiency of liposomal mTHPC. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[13]  F. Guillemin,et al.  Interaction of Liposomal Formulations of Meta‐tetra(hydroxyphenyl)chlorin (Temoporfin) with Serum Proteins: Protein Binding and Liposome Destruction , 2012, Photochemistry and photobiology.

[14]  Molly M Stevens,et al.  Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[15]  C. Maake,et al.  Photoinduced effects of m-tetrahydroxyphenylchlorin loaded lipid nanoemulsions on multicellular tumor spheroids , 2016, Journal of Nanobiotechnology.

[16]  E. Reddi,et al.  Uptake and photo-toxicity of Foscan®, Foslip® and Fospeg® in multicellular tumor spheroids. , 2016, Journal of photochemistry and photobiology. B, Biology.

[17]  Max J H Witjes,et al.  Photochemical internalization (PCI)‐mediated enhancement of bleomycin cytotoxicity by liposomal mTHPC formulations in human head and neck cancer cells , 2014, Lasers in surgery and medicine.

[18]  François Guillemin,et al.  Necrotic and apoptotic features of cell death in response to Foscan photosensitization of HT29 monolayer and multicell spheroids. , 2005, Biochemical pharmacology.

[19]  Hongxu Lu,et al.  Multicellular Tumor Spheroids (MCTS) as a 3D In Vitro Evaluation Tool of Nanoparticles. , 2018, Small.

[20]  R. Bonnett,et al.  Photobleaching of compounds of the 5,10,15,20-Tetrakis(m-hydroxyphenyl)porphyrin Series (m-THPP, m-THPC, and m-THPBC). , 2002, Organic letters.

[21]  R. Gurny,et al.  State of the art in the delivery of photosensitizers for photodynamic therapy. , 2002, Journal of photochemistry and photobiology. B, Biology.

[22]  M G Nichols,et al.  Fluence rate effects in photodynamic therapy of multicell tumor spheroids. , 1993, Cancer research.

[23]  T. Dougherty.  An update on photodynamic therapy applications. , 2002, Journal of clinical laser medicine & surgery.

[24]  V. Pandey,et al.  Ethosomes: versatile vesicular carriers for efficient transdermal delivery of therapeutic agents , 2015, Drug delivery.

[25]  T. Pellegrino,et al.  Cell-derived vesicles as a bioplatform for the encapsulation of theranostic nanomaterials. , 2013, Nanoscale.

[26]  Pieter Vader,et al.  Extracellular vesicles for drug delivery. , 2016, Advanced drug delivery reviews.

[27]  L. Bezdetnaya,et al.  Drug delivery to solid tumors: the predictive value of the multicellular tumor spheroid model for nanomedicine screening , 2017, International journal of nanomedicine.

[28]  F. Guillemin,et al.  Redistribution of meta-tetra(hydroxyphenyl)chlorin (m-THPC) from conventional and PEGylated liposomes to biological substrates , 2011, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[29]  M. Senge,et al.  Temoporfin (Foscan®, 5,10,15,20‐Tetra(m‐hydroxyphenyl)chlorin)—A Second‐generation Photosensitizer †,‡ , 2011, Photochemistry and photobiology.

[30]  G. Scherphof,et al.  Transfer and exchange of phospholipid between small unilamellar liposomes and rat plasma high density lipoproteins. Dependence on cholesterol content and phospholipid composition. , 1981, Biochimica et biophysica acta.

[31]  M. Bureau,et al.  Magnetic and photoresponsive theranosomes: translating cell-released vesicles into smart nanovectors for cancer therapy. , 2013, ACS nano.

[32]  François Guillemin,et al.  Investigation of Foscan interactions with plasma proteins. , 2005, Biochimica et biophysica acta.

[33]  Pieter Vader,et al.  Extracellular vesicles as drug delivery systems: lessons from the liposome field. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[34]  Han-Soo Kim,et al.  Engineering of extracellular vesicles as drug delivery vehicles. , 2017, Stem cell investigation.

[35]  L. Battistini,et al.  Acridine Orange/exosomes increase the delivery and the effectiveness of Acridine Orange in human melanoma cells: A new prototype for theranostics of tumors , 2017, Journal of enzyme inhibition and medicinal chemistry.

[36]  David Kessel,et al.  Photodynamic therapy of cancer: An update , 2011, CA: a cancer journal for clinicians.

[37]  S. May,et al.  Transfer mechanism of temoporfin between liposomal membranes. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[38]  G. Zheng,et al.  Liposomal nanostructures for photosensitizer delivery , 2011, Lasers in surgery and medicine.

[39]  A. Urbani,et al.  A Perspective on Extracellular Vesicles Proteomics , 2017, Front. Chem..

[40]  F. Guillemin,et al.  Assessment of Apoptosis by Immunohistochemistry to Active Caspase-3, Active Caspase-7, or Cleaved PARP in Monolayer Cells and Spheroid and Subcutaneous Xenografts of Human Carcinoma , 2009, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[41]  Gaurav Sahay,et al.  The exploitation of differential endocytic pathways in normal and tumor cells in the selective targeting of nanoparticulate chemotherapeutic agents. , 2010, Biomaterials.

[42]  José Villalaín,et al.  Influence of liposome charge and composition on their interaction with human blood serum proteins , 1993, Molecular and Cellular Biochemistry.

[43]  Alissa M. Weaver,et al.  Extracellular Vesicles: Unique Intercellular Delivery Vehicles. , 2017, Trends in cell biology.

[44]  Abraham H. Abouzeid,et al.  Cancer cell spheroids for screening of chemotherapeutics and drug-delivery systems. , 2015, Therapeutic delivery.

[45]  F. Guillemin,et al.  Characterization of Photodegradation of Meta‐tetra (Hydroxyphenyl)chlorin (mTHPC) in Solution: Biological Consequences in Human Tumor Cells , 1998, Photochemistry and photobiology.

[46]  P. Morlière,et al.  Endoplasmic reticulum and Golgi apparatus are the preferential sites of Foscan® localisation in cultured tumour cells , 2003, British Journal of Cancer.

[47]  F. Bonte,et al.  Interactions of liposomes with serum proteins. , 1986, Chemistry and physics of lipids.